CMS opens door for PET coverage for oncologic uses

03/9/2013 | HealthImaging.com · MedPage Today (free registration)

CMS has lifted the non-coverage decision for PET imaging for oncologic procedures, allowing local Medicare administrators to make decisions about coverage. The ruling, however, does not apply to cardiac and neurologic uses. SNMMI and other groups had lobbied for a broader decision. The decision applies to use of C-11 choline and other PET imaging agents for oncologic applications. The ruling does not address PET agents FDG, NaF-18, ammonia N-13 and rubidium-82, which already have been addressed with coverage determinations.

View Full Article in:

HealthImaging.com · MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT